Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersFRA:1SP +1.72%61 Debt-to-Equity is 2.43 as of Jun. 2026, which is 2% below its 10-year median of 2.48. GuruFocus rates FRA:1SP with a GF Score™ of 61/100 and a GF Value™ of €21.05 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 564 Healthcare Providers & Services companies, Surgery Partners ranks worse than 91.31% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Surgery Partners's Debt-to-Equity or its related term are showing as below:
FRA:1SP'
s Debt-to-Equity Range Over the Past 10 Years
Min: -173.05 Med: 2.48 Max: 300.48
Current: 2.43
During the past 13 years, the highest Debt-to-Equity Ratio of Surgery Partners was 300.48. The lowest was -173.05. And the median was 2.48.
FRA:1SP's Debt-to-Equity is ranked worse than 91.31% of 564
companies
in the Healthcare Providers & Services industry
Industry Median: 0.425
vs FRA:1SP: 2.43
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Surgery Partners Debt-to-Equity Related Terms
Surgery Partners Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Surgery Partners's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1SP vs SNDA, ASTH, AGL: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Surgery Partners's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Surgery Partners's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (FRA:1SP) has a Debt-to-Equity of 2.43 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Surgery Partners and its competitors. This is near median its historical median of 2.48. According to the industry distribution chart, Surgery Partners ranks #515 out of 564 companies in the Healthcare Providers & Services industry, placing it in the top 91.3%.
Is Surgery Partners' Debt-to-Equity too high?
Surgery Partners' current Debt-to-Equity of 2.43 is near median its 10-year median of 2.48. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. Surgery Partners' value of 2.43 is 471.8% above this industry median. Based on the distribution chart, Surgery Partners ranks #515 out of 564 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Surgery Partners has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' Debt-to-Equity compare to SNDA and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #515 out of 564 companies for Debt-to-Equity. This places Surgery Partners in the lower half of its industry. The industry median Debt-to-Equity is 0.43. Surgery Partners' value of 2.43 is 471.8% above this benchmark. While the company's 10-year median is 2.48 vs. the industry median of 0.43, Surgery Partners has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current Debt-to-Equity of 2.43 is 471.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current Debt-to-Equity is 2.43, which is near median its own 10-year median of 2.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (FRA:1SP) is currently considered Possible Value Trap. The stock's GF Value™ is €21.05, compared to a current price of €11.80 — trading 43.9% below its estimated fair value. The current Debt-to-Equity is 2.43, which is near median its 10-year median of 2.48 and 471.8% above the Healthcare Providers & Services industry median of 0.43. Surgery Partners' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Surgery Partners (FRA:1SP), the current Debt-to-Equity is 2.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (FRA:1SP) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of €11.80 is trading 43.9% below its estimated GF Value™ of €21.05.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for FRA:1SP:
Debt-to-Equity: 2.43 (near median its 10-year median of 2.48)
GF Value™: €21.05 vs. price of €11.80 (43.9% below fair value)
Industry Position: 471.8% above the Healthcare Providers & Services median (#515 of 564)
No single metric tells the full story. See the FRA:1SP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
61GF Score
Get the complete analysis for FRA:1SP
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1SP has been successfully added to your 
